Author

Garri Chilingaryan

Observed names: Chilingaryan, Garri, G. V. Chilingaryan, G.V. Chilingaryan, Garri V. Chilingaryan

Institution: Institute for Molecular Medicine

Observed institutions: Russian-Armenian University, Institute of Molecular Biology, Institute for Molecular Medicine, National Academy of Sciences of Armenia

ORCID: 0000-0001-7367-7678

Observed ORCID: 0000-0001-7367-7678

OpenAlex ID: A5017536032

Natural antimicrobial peptides as a source of new antiviral agents

2021 · Hovakim Zakaryan, Garri Chilingaryan, et al. · Journal of General Virology · 51

A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights

2021 · Mohammad M. Al-Sanea, Ahmad J. Obaidullah, et al. · Molecules · 40

Identification of Novel Potential VEGFR-2 Inhibitors Using a Combination of Computational Methods for Drug Discovery

2021 · Mohammad M. Al-Sanea, Garri Chilingaryan, et al. · Life · 30

Design, Synthesis and Anticancer Profile of New 4-(1H-benzo[d]imidazol-1-yl)pyrimidin-2-amine-Linked Sulfonamide Derivatives with V600EBRAF Inhibitory Effect

2021 · Mohammed S. Abdel-Maksoud, Ahmed A. B. Mohamed, et al. · International Journal of Molecular Sciences · 24

Combination of consensus and ensemble docking strategies for the discovery of human dihydroorotate dehydrogenase inhibitors

2021 · Garri Chilingaryan, Narek Abelyan, et al. · Scientific Reports · 24

A new microtubule-stabilizing agent shows potent antiviral effects against African swine fever virus with no cytotoxicity

2021 · Samvel Sirakanyan, Erik Arabyan, et al. · Emerging Microbes & Infections · 24

Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors

2022 · Mohammad M. Al-Sanea, Garri Chilingaryan, et al. · PLoS ONE · 20

mRNA Vaccine for Alzheimer’s Disease: Pilot Study

2024 · Armine Hovakimyan, Garri Chilingaryan, et al. · Vaccines · 16

Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery

2021 · Mohammad M. Al-Sanea, Garri Chilingaryan, et al. · Scientific Reports · 10

Targeting 3CLpro and SARS-CoV-2 RdRp by Amphimedon sp. Metabolites: A Computational Study

2021 · Nourhan Hisham Shady, Alaa M. Hayallah, et al. · Molecules · 9

MultiTEP-Based Vaccines Targeting SARS-CoV-2 Spike Protein IgG Epitopes Elicit Robust Binding Antibody Titers with Limited Virus-Neutralizing Activity

2024 · Tatevik Antonyan, Garri Chilingaryan, et al. · Pathogens · 2

Advanced virtual screening enables the discovery of a host-targeting and broad-spectrum antiviral agent

2023 · Garri Chilingaryan, Roza Izmailyan, et al. · Antiviral Research · 2

Design, antihuman immunodeficiency activity and molecular docking studies of synthesized 2-aryl and 2-pyrimidinyl pyrrolidines

2020 · Sahak P. Gasparyan, Ashot H. Martirosyan, et al. · Molecular Diversity · 2

Mode of Artemisinins’ Action on Oxidative Stress, Genomic and G-Quadruplex DNA

2019 · S. G. Ginosyan, G. V. Chilingaryan, et al. · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · 2

A randomized, placebo-controlled, double blind Phase 1 trial of the Aβ vaccine, AV-1959R, in non-cognitively impaired participants: prelude for secondary preventive therapy in preclinical AD

2026 · Armine Hovakimyan, Hovhannes Madoyan, et al. · Molecular Neurodegeneration

A new microtubule-stabilizing agent shows potent antiviral effects against African swine fever virus with no cytotoxicity

2021 · Sirakanyan, Samvel, Arabyan, Erik, et al. · Figshare

Investigation of the action of silver nanoparticles on the biosynthesis of podophyllotoxins of L. austriacum suspension cultures

2019 · A.A. Hovhannisyan, A.A. Arutyunyan, et al. · Toxicon

Works count: 17

Citation count: 256

H-index: 9

I10-index: 9